All stock lists
Gold Fields Limited (New York Stock Exchange:GFI)
ZA · Delayed Price · Currency is USD
Basic Materials · Gold
$35.78-$1.78 (-4.74%)
Market cap
$31.7B
Insider Score
Health Score
Analyst consensus
Listed since
Mar 17, 1980
Website
Insider Score
––Not scored
GFI Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
Financial Health Score
Strong
From GFI’s reported statements · Q2 2026 (trailing 12 months)
Profitability20 / 20
Keeps a healthy share of every dollar it sells.
- Revenue
- $17.80B
- Net income
- $6.29B
- Net margin
- 35.3%
Leverage20 / 20
Little or no net debt.
- Total debt
- $2.63B
- Cash
- $2.20B
- Net debt / EBITDA
- 0.04x
Liquidity18 / 20
Comfortably covers what is due within a year.
- Current assets
- $3.22B
- Current liabilities
- $1.72B
- Current ratio
- 1.87
Cash generation20 / 20
The business funds itself from operations.
- Operating cash flow
- $8.99B
- Free cash flow
- $6.20B
- FCF margin
- 34.8%
Dilution & runway20 / 20
Not funding itself by issuing shares.
- Shares outstanding
- 893.8M
- Share growth (1y)
- -0.2%
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
GFI Income Statement
| Fiscal Period | Q2 2026 | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Dec 31, 2025 | Jun 30, 2025 | Dec 31, 2024 | Jun 30, 2024 | Dec 31, 2023 |
| Revenue | $5.95 B | $5.29 B | $3.49 B | $3.08 B | $2.12 B | $2.23 B |
| Revenue Growth (YoY) | 180.02 % | 136.66 % | 53.85 % | 50.03 % | -4.98 % | 1.03 % |
| Cost of Revenue | $2.51 B | $2.29 B | $1.73 B | $1.23 B | $1.39 B | $1.86 B |
| Gross Profit | $3.44 B | $3.00 B | $1.76 B | $1.85 B | $735.00 M | $370.40 M |
| SG&A Expense | $170.70 M | $284.76 M | $138.56 M | $81.10 M | $82.40 M | $82.50 M |
| R&D Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Expenses | $170.70 M | $284.76 M | $138.56 M | $81.10 M | $82.40 M | -$9.83 M |
| Operating Income | $3.27 B | $2.71 B | $1.62 B | $1.77 B | $652.60 M | $676.80 M |
| Pretax Income | $3.11 B | $3.67 B | $1.64 B | $1.34 B | $682.80 M | $461.10 M |
| Tax Provision | $1.19 B | $1.07 B | $580.12 M | $450.40 M | $246.70 M | $190.50 M |
| Net Income | $1.86 B | $2.55 B | $1.03 B | $856.00 M | $389.00 M | $264.40 M |
| EPS (Basic) | $2.08 | $2.85 | $1.15 | $0.95 | $0.43 | $0.30 |
| EPS (Diluted) | $2.06 | $2.83 | $1.14 | $0.96 | $0.43 | $0.30 |
| Shares Outstanding | 893.79 M | 887.35 M | 895.02 M | 895.02 M | 895.45 M | 893.54 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.